Sandoz gets into the weeds with cannabis medical product manufacturer Tilray
The Canadian company's shares reached a high price after it signed a framework agreement with Novartis's generics arm that would enable global commercialization.
The Canadian company's shares reached a high price after it signed a framework agreement with Novartis's generics arm that would enable global commercialization.